1 Introduction to Research & Analysis Reports
1.1 Molecular Residual Disease Detection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Residual Disease Detection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Residual Disease Detection Overall Market Size
2.1 Global Molecular Residual Disease Detection Market Size: 2022 VS 2029
2.2 Global Molecular Residual Disease Detection Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Residual Disease Detection Players in Global Market
3.2 Top Global Molecular Residual Disease Detection Companies Ranked by Revenue
3.3 Global Molecular Residual Disease Detection Revenue by Companies
3.4 Top 3 and Top 5 Molecular Residual Disease Detection Companies in Global Market, by Revenue in 2022
3.5 Global Companies Molecular Residual Disease Detection Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Residual Disease Detection Players in Global Market
3.6.1 List of Global Tier 1 Molecular Residual Disease Detection Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Residual Disease Detection Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Molecular Residual Disease Detection Market Size Markets, 2022 & 2029
4.1.2 Tumor-informed Assays
4.1.3 Tumor-agnostic Assays
4.2 By Type – Global Molecular Residual Disease Detection Revenue & Forecasts
4.2.1 By Type – Global Molecular Residual Disease Detection Revenue, 2018-2023
4.2.2 By Type – Global Molecular Residual Disease Detection Revenue, 2024-2029
4.2.3 By Type – Global Molecular Residual Disease Detection Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Molecular Residual Disease Detection Market Size, 2022 & 2029
5.1.2 Prognosis
5.1.3 Adjuvant Treatment Decision-Making
5.1.4 Surveillance for Postoperative Recurrence
5.1.5 Other
5.2 By Application – Global Molecular Residual Disease Detection Revenue & Forecasts
5.2.1 By Application – Global Molecular Residual Disease Detection Revenue, 2018-2023
5.2.2 By Application – Global Molecular Residual Disease Detection Revenue, 2024-2029
5.2.3 By Application – Global Molecular Residual Disease Detection Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Molecular Residual Disease Detection Market Size, 2022 & 2029
6.2 By Region – Global Molecular Residual Disease Detection Revenue & Forecasts
6.2.1 By Region – Global Molecular Residual Disease Detection Revenue, 2018-2023
6.2.2 By Region – Global Molecular Residual Disease Detection Revenue, 2024-2029
6.2.3 By Region – Global Molecular Residual Disease Detection Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Molecular Residual Disease Detection Revenue, 2018-2029
6.3.2 US Molecular Residual Disease Detection Market Size, 2018-2029
6.3.3 Canada Molecular Residual Disease Detection Market Size, 2018-2029
6.3.4 Mexico Molecular Residual Disease Detection Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Molecular Residual Disease Detection Revenue, 2018-2029
6.4.2 Germany Molecular Residual Disease Detection Market Size, 2018-2029
6.4.3 France Molecular Residual Disease Detection Market Size, 2018-2029
6.4.4 U.K. Molecular Residual Disease Detection Market Size, 2018-2029
6.4.5 Italy Molecular Residual Disease Detection Market Size, 2018-2029
6.4.6 Russia Molecular Residual Disease Detection Market Size, 2018-2029
6.4.7 Nordic Countries Molecular Residual Disease Detection Market Size, 2018-2029
6.4.8 Benelux Molecular Residual Disease Detection Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Molecular Residual Disease Detection Revenue, 2018-2029
6.5.2 China Molecular Residual Disease Detection Market Size, 2018-2029
6.5.3 Japan Molecular Residual Disease Detection Market Size, 2018-2029
6.5.4 South Korea Molecular Residual Disease Detection Market Size, 2018-2029
6.5.5 Southeast Asia Molecular Residual Disease Detection Market Size, 2018-2029
6.5.6 India Molecular Residual Disease Detection Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Molecular Residual Disease Detection Revenue, 2018-2029
6.6.2 Brazil Molecular Residual Disease Detection Market Size, 2018-2029
6.6.3 Argentina Molecular Residual Disease Detection Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Molecular Residual Disease Detection Revenue, 2018-2029
6.7.2 Turkey Molecular Residual Disease Detection Market Size, 2018-2029
6.7.3 Israel Molecular Residual Disease Detection Market Size, 2018-2029
6.7.4 Saudi Arabia Molecular Residual Disease Detection Market Size, 2018-2029
6.7.5 UAE Molecular Residual Disease Detection Market Size, 2018-2029
7 Molecular Residual Disease Detection Companies Profiles
7.1 Adaptive
7.1.1 Adaptive Company Summary
7.1.2 Adaptive Business Overview
7.1.3 Adaptive Molecular Residual Disease Detection Major Product Offerings
7.1.4 Adaptive Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.1.5 Adaptive Key News & Latest Developments
7.2 Guardant Health
7.2.1 Guardant Health Company Summary
7.2.2 Guardant Health Business Overview
7.2.3 Guardant Health Molecular Residual Disease Detection Major Product Offerings
7.2.4 Guardant Health Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.2.5 Guardant Health Key News & Latest Developments
7.3 Invitae
7.3.1 Invitae Company Summary
7.3.2 Invitae Business Overview
7.3.3 Invitae Molecular Residual Disease Detection Major Product Offerings
7.3.4 Invitae Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.3.5 Invitae Key News & Latest Developments
7.4 Cergentis B.V
7.4.1 Cergentis B.V Company Summary
7.4.2 Cergentis B.V Business Overview
7.4.3 Cergentis B.V Molecular Residual Disease Detection Major Product Offerings
7.4.4 Cergentis B.V Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.4.5 Cergentis B.V Key News & Latest Developments
7.5 LexentBio
7.5.1 LexentBio Company Summary
7.5.2 LexentBio Business Overview
7.5.3 LexentBio Molecular Residual Disease Detection Major Product Offerings
7.5.4 LexentBio Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.5.5 LexentBio Key News & Latest Developments
7.6 Natera
7.6.1 Natera Company Summary
7.6.2 Natera Business Overview
7.6.3 Natera Molecular Residual Disease Detection Major Product Offerings
7.6.4 Natera Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.6.5 Natera Key News & Latest Developments
7.7 BGI
7.7.1 BGI Company Summary
7.7.2 BGI Business Overview
7.7.3 BGI Molecular Residual Disease Detection Major Product Offerings
7.7.4 BGI Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.7.5 BGI Key News & Latest Developments
7.8 Zhiben Medical
7.8.1 Zhiben Medical Company Summary
7.8.2 Zhiben Medical Business Overview
7.8.3 Zhiben Medical Molecular Residual Disease Detection Major Product Offerings
7.8.4 Zhiben Medical Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.8.5 Zhiben Medical Key News & Latest Developments
7.9 Burning Rock Medicine
7.9.1 Burning Rock Medicine Company Summary
7.9.2 Burning Rock Medicine Business Overview
7.9.3 Burning Rock Medicine Molecular Residual Disease Detection Major Product Offerings
7.9.4 Burning Rock Medicine Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.9.5 Burning Rock Medicine Key News & Latest Developments
7.10 Huidu Medical
7.10.1 Huidu Medical Company Summary
7.10.2 Huidu Medical Business Overview
7.10.3 Huidu Medical Molecular Residual Disease Detection Major Product Offerings
7.10.4 Huidu Medical Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.10.5 Huidu Medical Key News & Latest Developments
7.11 Zhenhe Technology
7.11.1 Zhenhe Technology Company Summary
7.11.2 Zhenhe Technology Business Overview
7.11.3 Zhenhe Technology Molecular Residual Disease Detection Major Product Offerings
7.11.4 Zhenhe Technology Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.11.5 Zhenhe Technology Key News & Latest Developments
7.12 ExactSciences
7.12.1 ExactSciences Company Summary
7.12.2 ExactSciences Business Overview
7.12.3 ExactSciences Molecular Residual Disease Detection Major Product Offerings
7.12.4 ExactSciences Molecular Residual Disease Detection Revenue in Global Market (2018-2023)
7.12.5 ExactSciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Table 1. Molecular Residual Disease Detection Market Opportunities & Trends in Global Market
Table 2. Molecular Residual Disease Detection Market Drivers in Global Market
Table 3. Molecular Residual Disease Detection Market Restraints in Global Market
Table 4. Key Players of Molecular Residual Disease Detection in Global Market
Table 5. Top Molecular Residual Disease Detection Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Molecular Residual Disease Detection Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Molecular Residual Disease Detection Revenue Share by Companies, 2018-2023
Table 8. Global Companies Molecular Residual Disease Detection Product Type
Table 9. List of Global Tier 1 Molecular Residual Disease Detection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Molecular Residual Disease Detection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Molecular Residual Disease Detection Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Molecular Residual Disease Detection Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Molecular Residual Disease Detection Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Molecular Residual Disease Detection Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Molecular Residual Disease Detection Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Molecular Residual Disease Detection Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Molecular Residual Disease Detection Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Molecular Residual Disease Detection Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Molecular Residual Disease Detection Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Molecular Residual Disease Detection Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Molecular Residual Disease Detection Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Molecular Residual Disease Detection Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Molecular Residual Disease Detection Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Molecular Residual Disease Detection Revenue, (US$, Mn), 2024-2029
Table 30. Adaptive Company Summary
Table 31. Adaptive Molecular Residual Disease Detection Product Offerings
Table 32. Adaptive Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 33. Adaptive Key News & Latest Developments
Table 34. Guardant Health Company Summary
Table 35. Guardant Health Molecular Residual Disease Detection Product Offerings
Table 36. Guardant Health Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 37. Guardant Health Key News & Latest Developments
Table 38. Invitae Company Summary
Table 39. Invitae Molecular Residual Disease Detection Product Offerings
Table 40. Invitae Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 41. Invitae Key News & Latest Developments
Table 42. Cergentis B.V Company Summary
Table 43. Cergentis B.V Molecular Residual Disease Detection Product Offerings
Table 44. Cergentis B.V Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 45. Cergentis B.V Key News & Latest Developments
Table 46. LexentBio Company Summary
Table 47. LexentBio Molecular Residual Disease Detection Product Offerings
Table 48. LexentBio Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 49. LexentBio Key News & Latest Developments
Table 50. Natera Company Summary
Table 51. Natera Molecular Residual Disease Detection Product Offerings
Table 52. Natera Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 53. Natera Key News & Latest Developments
Table 54. BGI Company Summary
Table 55. BGI Molecular Residual Disease Detection Product Offerings
Table 56. BGI Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 57. BGI Key News & Latest Developments
Table 58. Zhiben Medical Company Summary
Table 59. Zhiben Medical Molecular Residual Disease Detection Product Offerings
Table 60. Zhiben Medical Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 61. Zhiben Medical Key News & Latest Developments
Table 62. Burning Rock Medicine Company Summary
Table 63. Burning Rock Medicine Molecular Residual Disease Detection Product Offerings
Table 64. Burning Rock Medicine Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 65. Burning Rock Medicine Key News & Latest Developments
Table 66. Huidu Medical Company Summary
Table 67. Huidu Medical Molecular Residual Disease Detection Product Offerings
Table 68. Huidu Medical Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 69. Huidu Medical Key News & Latest Developments
Table 70. Zhenhe Technology Company Summary
Table 71. Zhenhe Technology Molecular Residual Disease Detection Product Offerings
Table 72. Zhenhe Technology Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 73. Zhenhe Technology Key News & Latest Developments
Table 74. ExactSciences Company Summary
Table 75. ExactSciences Molecular Residual Disease Detection Product Offerings
Table 76. ExactSciences Molecular Residual Disease Detection Revenue (US$, Mn) & (2018-2023)
Table 77. ExactSciences Key News & Latest Developments
List of Figures
Figure 1. Molecular Residual Disease Detection Segment by Type in 2022
Figure 2. Molecular Residual Disease Detection Segment by Application in 2022
Figure 3. Global Molecular Residual Disease Detection Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Molecular Residual Disease Detection Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Molecular Residual Disease Detection Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Molecular Residual Disease Detection Revenue in 2022
Figure 8. By Type - Global Molecular Residual Disease Detection Revenue Market Share, 2018-2029
Figure 9. By Application - Global Molecular Residual Disease Detection Revenue Market Share, 2018-2029
Figure 10. By Type - Global Molecular Residual Disease Detection Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Molecular Residual Disease Detection Revenue Market Share, 2018-2029
Figure 12. By Application - Global Molecular Residual Disease Detection Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Molecular Residual Disease Detection Revenue Market Share, 2018-2029
Figure 14. By Region - Global Molecular Residual Disease Detection Revenue Market Share, 2018-2029
Figure 15. By Country - North America Molecular Residual Disease Detection Revenue Market Share, 2018-2029
Figure 16. US Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Molecular Residual Disease Detection Revenue Market Share, 2018-2029
Figure 20. Germany Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 21. France Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Molecular Residual Disease Detection Revenue Market Share, 2018-2029
Figure 28. China Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 32. India Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Molecular Residual Disease Detection Revenue Market Share, 2018-2029
Figure 34. Brazil Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Molecular Residual Disease Detection Revenue Market Share, 2018-2029
Figure 37. Turkey Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Molecular Residual Disease Detection Revenue, (US$, Mn), 2018-2029
Figure 41. Adaptive Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Guardant Health Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Invitae Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cergentis B.V Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. LexentBio Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Natera Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. BGI Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Zhiben Medical Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Burning Rock Medicine Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Huidu Medical Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Zhenhe Technology Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. ExactSciences Molecular Residual Disease Detection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer